Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-751 + Pemetrexed in Advanced/Metastatic NSCLC
NCT00297089Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Nov 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of abt-751 in non-small cell lung cancer (NSCLC), sponsored by AbbVie Inc.. Started Nov 2006; status: completed.
02
Drugs
abt-751
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00297089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00297089.